Shen-Ming Huang,Meng-Yao Xiong,Lei Liu,Jianqiang Mu,Ming-Wei Wang,Ying-Li Jia,Kui Cai,Lu Tie,Chao Zhang,Sheng Cao,Xin Wen,Jia-Le Wang,Sheng-Chao Guo,Yu Li,Chang-Xiu Qu,Qing-Tao He,Bo-Yang Cai,Chenyang Xue,Shiyi Gan,Yihe Xie,Xin Cong,Zhao Yang,Wei Kong,Shuo Li,Zijian Li,Peng Xiao,Fan Yang,Xiao Yu,You-Fei Guan,Xiaoyan Zhang,Zhongmin Liu,Bao-Xue Yang,Yan Du,Jin-Peng Sun

Abstract:To accomplish concerted physiological reactions, nature has diversified functions of a single hormone at at least two primary levels: 1) Different receptors recognize the same hormone, and 2) different cellular effectors couple to the same hormone-receptor pair [R.P. Xiao, Sci STKE 2001, re15 (2001); L. Hein, J. D. Altman, B.K. Kobilka, Nature 402, 181-184 (1999); Y. Daaka, L. M. Luttrell, R. J. Lefkowitz, Nature 390, 88-91 (1997)]. Not only these questions lie in the heart of hormone actions and receptor signaling but also dissecting mechanisms underlying these questions could offer therapeutic routes for refractory diseases, such as kidney injury (KI) or X-linked nephrogenic diabetes insipidus (NDI). Here, we identified that Gs-biased signaling, but not Gi activation downstream of EP4, showed beneficial effects for both KI and NDI treatments. Notably, by solving Cryo-electron microscope (cryo-EM) structures of EP3-Gi, EP4-Gs, and EP4-Gi in complex with endogenous prostaglandin E2 (PGE2)or two synthetic agonists and comparing with PGE2-EP2-Gs structures, we found that unique primary sequences of prostaglandin E2 receptor (EP) receptors and distinct conformational states of the EP4 ligand pocket govern the Gs/Gi transducer coupling selectivity through different structural propagation paths, especially via TM6 and TM7, to generate selective cytoplasmic structural features. In particular, the orientation of the PGE2 ω-chain and two distinct pockets encompassing agonist L902688 of EP4 were differentiated by their Gs/Gi coupling ability. Further, we identified common and distinct features of cytoplasmic side of EP receptors for Gs/Gi coupling and provide a structural basis for selective and biased agonist design of EP4 with therapeutic potential.

Structural basis for the ligand recognition and G protein subtype selectivity of kisspeptin receptor

Structural basis for hormone recognition and distinctive Gq protein coupling by the kisspeptin receptor

Single Hormone or Synthetic Agonist Induces Gs/Gi Coupling Selectivity of EP Receptors Via Distinct Binding Modes and Propagating Paths.

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Ligand recognition and G-protein coupling selectivity of cholecystokinin A receptor

Structural Understanding of Peptide-Bound G Protein-Coupled Receptors: Peptide-Target Interactions.

Structural basis for ligand recognition and G protein-coupling promiscuity of the cholecystokinin A receptor

Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein

Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E<sub>2</sub> receptor EP2 subtype

Structural insights into adhesion GPCR ADGRL3 activation and Gq, Gs, Gi, and G12 coupling

[Single-Particle Cryo-Electron Microscopy Opens New Avenues in Structural Biology of G Protein-Coupled Receptor].

Structure and Ligand Recognition of Class C GPCRs

Conformational Transitions and Activation of the Adhesion Receptor CD97.

Structures of the human cholecystokinin receptors bound to agonists and antagonists

A dual fluorescence reporter system for high throughput screening of effectors of Kiss1 gene expression.

Structure and dynamics determine G protein coupling specificity at a class A GPCR

A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2

Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling

Molecular Determinant Underlying Selective Coupling of Primary G-Protein by Class A GPCRs

A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor

Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8